Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
about
Genome-Wide Identification of Antimicrobial Intrinsic Resistance Determinants in Staphylococcus aureusInhibition of the MurA enzyme in Fusobacterium nucleatum by potential inhibitors identified through computational and in vitro approaches.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaCharacterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in TaiwanClinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.Fosfomycin: Mechanism and Resistance.Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France.Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.Inhibition of fosfomycin resistance protein FosA by phosphonoformate (foscarnet) in multidrug-resistant Gram-negative pathogens.Plasmids of Diverse Inc Groups Disseminate the Fosfomycin Resistance Gene fosA3 among Escherichia coli Isolates from Pigs, Chickens, and Dairy Cows in Northeast China.Bacteriology and Antibiogram of Urinary Tract Infection Among Female Patients in a Tertiary Health Facility in South Eastern Nigeria.Fosfomycin: Pharmacological, Clinical and Future Perspectives.Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.Origin of the plasmid-mediated fosfomycin resistance gene fosA3.Epistatic control of intrinsic resistance by virulence genes in ListeriaAntibacterial and photochemical properties of cellulose nanofiber–titania nanocomposites loaded with two different types of antibiotic medicinesCellulose nanofiber–titania nanocomposites as potential drug delivery systems for dermal applications
P2860
Q28354064-343FF577-A6C5-4C1D-86D4-2F60442EBD3DQ30152646-C78A4887-D979-4732-8F08-448C82ECB4F3Q33600161-DF592BEB-861A-4A11-8D82-1CDA5F792930Q35747796-011A7E2E-B437-4140-BEA3-EB9266C39439Q36290521-019C2D69-20CD-4752-A7C5-EB3F41EE1A47Q38689344-1B2AD14C-93B9-4B35-A333-F9036B812F58Q38833839-985FF752-2311-4E57-828F-5D29B4D97632Q39071416-312BD4F5-5D85-466B-855F-D78E14CFABCBQ40088503-9094A4FD-336B-4587-8145-F7C097E88211Q40645840-7EFD48EA-259C-4C2A-82E4-97B73EC6A9C2Q41989392-994C23D6-70EC-4321-8FCA-438539D41FD9Q42016011-63FDD6E1-87E9-4DDD-B30D-70E381483B36Q46194780-04ED637B-CCC4-4165-B7BC-F9B28C581543Q47136072-1D25A524-E76D-4DE4-B95B-1DBD8A5131AAQ48179364-734DAE4A-85C2-4BA6-9F99-7B81237DEBCDQ48380261-A9EC1194-F774-463A-862D-438CE249AFC4Q50140816-CAF3861E-85D7-4A7B-8099-F611DE20C30DQ57008716-23E5331C-888B-4AE5-BE97-3418403B156EQ58333662-98C954BE-51B4-42D7-951E-3F032C2A8343Q58333665-C9F282E7-60D0-41CC-BB6F-240BDF4C2053
P2860
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@ast
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@en
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@nl
type
label
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@ast
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@en
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@nl
prefLabel
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@ast
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@en
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@nl
P2860
P1476
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
@en
P2093
Alexandro Rodríguez-Rojas
Alfredo Castañeda-García
P2860
P304
P356
10.3390/ANTIBIOTICS2020217
P407
P50
P577
2013-04-16T00:00:00Z